GlycoMimetics (GLYC) Reports In-Line Q3 EPS

GlycoMimetics (NASDAQ: GLYC) reported Q3 EPS of ($0.14), in-line with the analyst estimate of ($0.14). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on GlycoMimetics (GLYC) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Wall Street scrambles to lift Micron price targets ahead of earnings
• Accenture (ACN) Tops Q3 EPS by 8c, Misses on Revenue; Offers FY26 EPS Guidance